-
Patients with New York Heart Association class II or class III congestive heart failure and a left ventricular ejection fraction of 35% or less benefit from ICD therapy but not from amiodarone therapy.
-
Two articles have been recently published emphasizing the importance of C-reactive protein in statin treated patients.
-
A fixed combination of the narcotic analgesic oxycodone and the nonsteroidal anti-inflammatory agent ibuprofen has been approved for the short-term treatment of acute moderate-to-severe pain. This first time combination of these 2 agents is marketed by Forest Laboratories as CombunoxTM.
-
Although irritable bowel syndrome is mostly viewed as a nuisance disease without serious consequences, a surprisingly large number of IBS patients may suffer severe depression, hopelessness, and consequential suicidal ideation.
-
The addition of niacin to patients with known CAD on statins raised HDL cholesterol and reduced atherosclerosis progression.
-
A single fecal occult blood test from a digital rectal exam specimen does not provide adequate screening for colorectal neoplasia and cannot replace standard at-home 6-sample fecal occult blood testing.
-
Obesity is an important, potentially modifiable risk factor for AF. The excess risk of AF associated with obesity appears to be mediated by left atrial dilatation. These prospective data raise the possibility that interventions to promote normal weight may reduce the population burden of AF.
-
Erectile dysfunction is commonplace in men at middle-age and beyond, the same era when hypertension incidence begins to rise steeply.
-
Adherence to any diet was the best predictor of weight loss, which predicted degree of improvement in cardiac risk markers.
-
Facts about cancer pain. Part 2: Non-drug treatments for pain. Altern Med Alert 2005;8(suppl 3):S1-S4.